In a milestone achievement for both quantum computing and high-energy physics, an international research collective led by the Duke Quantum…
Read More
BioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery Collaboration
In a significant move bridging artificial intelligence and biotechnology, BioMarin Pharmaceutical has forged a strategic research collaboration with Emeryville-based tech…
Read More
Sanofi and Regeneron Expand Landmark Pharma Alliance in $8bn Deal to Co-Develop Next-Generation Long-Acting Antibodies
Building upon one of the most successful and enduring scientific partnerships in the history of the modern pharmaceutical industry, French…
Read More
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Tolerance Bio has finalized a high-stakes licensing agreement with Tanabe Pharma, acquiring exclusive worldwide commercialization rights—excluding Japan—for TLB-33, a clinical-stage…
Read More
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Acute myelogenous leukemia (AML) remains one of the most formidable and aggressive malignancies in modern oncology. Characterized by rapid progression…
Read More
Illumina TruPath Genome and DRAGEN Algorithm Unlock High-Resolution Analysis of Complex Genomic Regions in Landmark Whole-Genome Sequencing Advance
Genomic research has long faced a formidable bottleneck in deciphering the most complex regions of the human genome, particularly those…
Read More
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before Diagnosis
Recent findings published in the prestigious journal Nature have fundamentally shifted our scientific understanding of chronic myeloid leukemia (CML), a…
Read More
Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Australia-based radiopharmaceutical leader Telix Pharmaceuticals has entered into a definitive agreement to acquire Germany’s ITM Isotope Technologies Munich in a…
Read More
Scholar Rock Secures Landmark FDA Approval for Isemblyd, Ushering in a New Era of Muscle-Targeted Spinal Muscular Atrophy Treatments
The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More
Unraveling Millipede Origins: Landmark Study Rewrites Evolutionary History of Ancient Terrestrial Pioneers
Centuries before the reign of dinosaurs and long before the first vertebrates dared to venture onto land, millipedes were already…
Read More
